Following an initial administrative conference call, clinical leadership conducted calls to review causes of high pressure ulcers rates, including program adherence, formulary-based prevention strategies, workflow, wound etiology, and understanding/adherence to reporting guidelines. Action plans were developed to address the deficits. HAPU rates were the number of HAPUs divided by patient days times 1,000. HAPU rates were compared 6-months pre- and 6-months post- MP implementation in 9 MP and 9 randomly selected control group LTACHs. A General Linear Model with repeated measures was used to determine the significance of the mean HAPU rate changes
For the 9 MP LTACHs, the average HAPU rate decreased from a pre-implementation rate of 6.09 HAPUs [95% CI: 4.98, 7.20], to a post-implementation rate of 2.78 HAPUs [95% CI: 1.08, 4.49] (GLM repeated measures design; F (1, 8) = 17.025, p = .003; partial eta squared = .680). A control group of a random sample of 9 LTACHs that did not participate in the MP program had no significant change in HAPU rates pre- to post- MP implementation. Overall average HAPU rate from the MP LTACHs began declining prior to implementation of the MP but decreased at a more rapid rate following MP implementation.
A mentoring program drilled down into causative factors associated with elevated HAPU rates was shown to be successful in significantly reducing HAPU rates in LTACHs that had a history of elevated HAPU rates. Similar programs may be effective in reducing HAPUs in high acuity and other critical care settings.